March 8, 2010
Research presented at the 17th Conference on Retroviruses and Opportunistic Infections indicates a new class of antiretroviral drugs called CCR5 entry inhibitors could be used to produce an effective microbicide against HIV. The drugs block HIV from entering human cells using a type of cellular doorway or receptor named CCR5.
02.19.2010; Maggie Fox
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.